Breaking News Instant updates and real-time market news.

GAIA

Gaia

$10.53 /

+0.795 (+8.17%)

08:43
03/02/21
03/02
08:43
03/02/21
08:43

Gaia price target raised to $20 from $18 at Lake Street

Lake Street analyst Mark Argento raised the firm's price target on Gaia to $20 from $18 and keeps a Buy rating on the shares after the company reported a quarter that he said featured "another strong beat across the board." Unlike "other higher profile pubic streaming video plays," Gaia "is quietly going about its business" while proving that it can both self-fund growth and generate free cash flow, Argento tells investors.

  • 15

    Mar

GAIA Gaia
$10.53 /

+0.795 (+8.17%)

11/10/20 Lake Street
Gaia price target raised to $18 from $15 at Lake Street
06/10/20 B. Riley
Gaia can re-rate meaningfully over next year, says B. Riley FBR
05/15/20 B. Riley
Gaia shares offer 'significant re-rating' potential, says B. Riley FBR
04/28/20 Lake Street
Gaia Q1 in line when excluding live events, says Lake Street

TODAY'S FREE FLY STORIES

Recommendations
Edwards Lifesciences price target raised to $105 from $97 at Piper Sandler » 04:59
04/21/21
04/21
04:59
04/21/21
04:59
EW

Edwards Lifesciences

$89.62 /

+1.16 (+1.31%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

04/15/21 Atlantic Equities
Atlantic Equities starts Edwards Lifesciences at Neutral
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/05/21 Evercore ISI
Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

EW Edwards Lifesciences
$89.62 /

+1.16 (+1.31%)

Recommendations
Intuitive Surgical price target raised to $840 from $735 at Piper Sandler » 04:58
04/21/21
04/21
04:58
04/21/21
04:58
ISRG

Intuitive Surgical

$809.85 /

-0.91 (-0.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Citi
Intuitive Surgical initiated with a Buy at Citi
03/31/21 Piper Sandler
Intuitive Surgical price target raised to $735 from $730 at Piper Sandler
ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

ISRG Intuitive Surgical
$809.85 /

-0.91 (-0.11%)

Upgrade
CSX upgraded to Outperform from Market Perform at BMO Capital » 04:56
04/21/21
04/21
04:56
04/21/21
04:56
CSX

CSX

$98.51 /

-0.18 (-0.18%)

BMO Capital analyst Fadi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$98.51 /

-0.18 (-0.18%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

03/26/21 Vertical Research
CSX reinstated with a Hold at Vertical Research
03/25/21 Citi
Norfolk Southern shares have another $100 of potential upside, says Citi
01/25/21 Argus
CSX price target raised to $98 from $90 at Argus
01/22/21
Fly Intel: Top five analyst downgrades
CSX CSX
$98.51 /

-0.18 (-0.18%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

CSX CSX
$98.51 /

-0.18 (-0.18%)

Conference/Events
Jefferies consumer services analyst to hold analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
TMX

Terminix

$47.95 /

-0.36 (-0.75%)

, ROL

Rollins

$35.18 /

+0.375 (+1.08%)

Consumer Services Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMX Terminix
$47.95 /

-0.36 (-0.75%)

ROL Rollins
$35.18 /

+0.375 (+1.08%)

TMX Terminix
$47.95 /

-0.36 (-0.75%)

11/06/20 Baird
Terminix upgraded to Outperform at Baird
11/06/20 Baird
Terminix upgraded to Outperform from Neutral at Baird
10/16/20 Stifel
Terminix added to Select List at Stifel
ROL Rollins
$35.18 /

+0.375 (+1.08%)

06/05/20 Stifel
Rollins takeout seems unlikely given current valuation, says Stifel
TMX Terminix
$47.95 /

-0.36 (-0.75%)

ROL Rollins
$35.18 /

+0.375 (+1.08%)

Conference/Events
UBS airlines analysts to hold analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Industrial Goods Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS electric equip/multi-industry analysts hold analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Electrical Equipment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
ABBV

AbbVie

$109.03 /

+0.43 (+0.40%)

, ABC

AmerisourceBergen

$120.47 /

+0.98 (+0.82%)

, ABT

Abbott

$120.00 /

-4.67 (-3.75%)

, ACAD

Acadia Pharmaceuticals

$20.79 /

+0.01 (+0.05%)

, ALNY

Alnylam

$135.74 /

-1.55 (-1.13%)

, BIIB

Biogen

$272.95 /

+4.05 (+1.51%)

, BMY

Bristol-Myers

$66.06 /

+0.4 (+0.61%)

, BHVN

Biohaven Pharmaceutical

$73.50 /

+1.22 (+1.69%)

, CPRX

Catalyst Pharmaceuticals

$4.39 /

+0.07 (+1.62%)

, DGX

Quest Diagnostics

$129.37 /

-1.69 (-1.29%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$91.07 /

+0.88 (+0.98%)

, LIVN

LivaNova

$81.39 /

+0.74 (+0.92%)

, LLY

Eli Lilly

$190.55 /

+0.85 (+0.45%)

, MDT

Medtronic

$128.29 /

+2.13 (+1.69%)

, NVS

Novartis

$87.84 /

-0.52 (-0.59%)

, NVTA

Invitae

$34.25 /

-1.08 (-3.06%)

, PFE

Pfizer

$39.03 /

+0.09 (+0.23%)

, PTCT

PTC Therapeutics

$46.26 /

-1.27 (-2.67%)

, RETA

Reata Pharmaceuticals

$89.28 /

-1.62 (-1.78%)

, SNY

Sanofi

$51.98 /

+0.12 (+0.23%)

, SUPN

Supernus

$30.69 /

-0.24 (-0.78%)

, TAK

Takeda Pharmaceutical

$16.84 /

-0.12 (-0.71%)

, TEVA

Teva

$10.12 /

-0.175 (-1.70%)

, TGTX

TG Therapeutics

$39.95 /

-2.88 (-6.72%)

, ZGNX

Zogenix

$18.79 /

-0.1 (-0.53%)

, AVDL

Avadel Pharmaceuticals

$8.17 /

-0.3 (-3.54%)

, JNJ

Johnson & Johnson

$166.47 /

+3.66 (+2.25%)

73rd Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$120.00 /

-4.67 (-3.75%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$272.95 /

+4.05 (+1.51%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$128.29 /

+2.13 (+1.69%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$87.84 /

-0.52 (-0.59%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$34.25 /

-1.08 (-3.06%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.03 /

+0.09 (+0.23%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.98 /

+0.12 (+0.23%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$30.69 /

-0.24 (-0.78%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.12 /

-0.175 (-1.70%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

Conference/Events
Roche to host sales conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
RHHBY

Roche

$42.02 /

-0.26 (-0.61%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$42.02 /

-0.26 (-0.61%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
RHHBY Roche
$42.02 /

-0.26 (-0.61%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

Conference/Events
Cowen basic materials analyst to hold an analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Basic Materials Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Achieve Life Sciences participates in a conf call hosted by Lake Street » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
ACHV

Achieve Life Sciences

$9.52 /

-0.6 (-5.93%)

Lake Street to host…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHV Achieve Life Sciences
$9.52 /

-0.6 (-5.93%)

09/17/20 Lake Street
Achieve Life Sciences initiated with a Buy at Lake Street
ACHV Achieve Life Sciences
$9.52 /

-0.6 (-5.93%)

  • 03
    Dec
Conference/Events
Altimmune management to meet virtually with JMP Securities » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
ALT

Altimmune

$11.82 /

+0.025 (+0.21%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$11.82 /

+0.025 (+0.21%)

ALT Altimmune
$11.82 /

+0.025 (+0.21%)

03/26/21 Piper Sandler
AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
02/18/21 B. Riley Securities
Altimmune price target raised to $41 from $28 at B. Riley Securities
02/17/21 Piper Sandler
Piper remains bullish on Altimmune after FDA clears Covid vaccine trial
02/10/21 Guggenheim
Altimmune initiated with a Buy at Guggenheim
ALT Altimmune
$11.82 /

+0.025 (+0.21%)

  • 14
    Jul
ALT Altimmune
$11.82 /

+0.025 (+0.21%)

ALT Altimmune
$11.82 /

+0.025 (+0.21%)

Conference/Events
Processa Pharmaceuticals management to meet virtually with Benchmark » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
PCSA

Processa Pharmaceuticals

$8.09 /

-0.77 (-8.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$8.09 /

-0.77 (-8.69%)

PCSA Processa Pharmaceuticals
$8.09 /

-0.77 (-8.69%)

12/08/20 Benchmark
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Conference/Events
Jefferies basic materials analyst to hold an analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Basic Materials Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley commodities strategist to hold analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Head of ETFs & Swaps…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Morgan Stanley REITs analyst to hold analyst/industry conference call » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

REITs Analyst Malhotra…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
BioCardia participates in a conference call with Maxim » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
BCDA

BioCardia

$3.49 /

-0.15 (-4.12%)

Biotechnology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$3.49 /

-0.15 (-4.12%)

BCDA BioCardia
$3.49 /

-0.15 (-4.12%)

04/16/21 Dawson James
Dawson James downgrades BioCardia, sees capital raise this year
04/16/21 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Alliance Global Partners
BioCardia initiated with a Buy at Alliance Global Partners
BCDA BioCardia
$3.49 /

-0.15 (-4.12%)

BCDA BioCardia
$3.49 /

-0.15 (-4.12%)

Conference/Events
Paychex management to meet virtually with Oppenheimer » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
PAYX

Paychex

$97.52 /

+1.12 (+1.16%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAYX Paychex
$97.52 /

+1.12 (+1.16%)

PAYX Paychex
$97.52 /

+1.12 (+1.16%)

04/07/21 Baird
Paychex price target raised to $94 from $82 at Baird
04/07/21 Argus
Paychex price target raised to $105 from $103 at Argus
04/07/21 BMO Capital
Paychex price target raised to $96 from $93 at BMO Capital
04/07/21 Goldman Sachs
Goldman boosts Paychex target, keeps Sell rating on valuation
PAYX Paychex
$97.52 /

+1.12 (+1.16%)

PAYX Paychex
$97.52 /

+1.12 (+1.16%)

Conference/Events
Protara Therapeutics management to meet virtually with Oppenheimer » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
TARA

Protara Therapeutics

$14.79 /

-0.4 (-2.63%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$14.79 /

-0.4 (-2.63%)

TARA Protara Therapeutics
$14.79 /

-0.4 (-2.63%)

10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Guggenheim
Protara Therapeutics started with Buy rating, $50 target at Guggenheim
07/29/20 Guggenheim
Protara Therapeutics initiated with a Buy at Guggenheim
TARA Protara Therapeutics
$14.79 /

-0.4 (-2.63%)

  • 22
    Sep
Conference/Events
MGM Resorts to host analyst and investor virtual meeting » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
MGM

MGM Resorts

$39.55 /

-0.2 (-0.50%)

Virtual Analyst &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/05/21
Fly Intel: Top five analyst upgrades
04/05/21 Morgan Stanley
Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit
MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

MGM MGM Resorts
$39.55 /

-0.2 (-0.50%)

Conference/Events
SNN Network to hold a virtual event » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
VMAR

Vision Marine Technologies

$6.09 /

-0.095 (-1.54%)

, GROW

U.S. Global Investors

$7.26 /

-0.38 (-4.97%)

, PYR

PyroGenesis

$4.90 /

-0.02 (-0.41%)

, SKYE

Skye Bioscience

/

+

, MEDS

Trxade Group

$4.26 /

-0.05 (-1.16%)

, ENVB

Enveric Biosciences

$2.16 /

-0.12 (-5.26%)

, SOLO

ElectraMeccanica

$3.95 /

-0.115 (-2.83%)

, DUOT

Duos Technologies Group

$7.99 /

-0.01 (-0.13%)

, CTHR

Charles & Colvard

$2.79 /

-0.16 (-5.42%)

, BMM

Bimini Mortgage Management

/

+

, ARHH

Assure Holdings

$1.24 /

-0.00099 (-0.08%)

, HSDT

Helius Medical

$17.09 /

-0.225 (-1.30%)

, ISDR

Issuer Direct

$24.52 /

+0.6 (+2.51%)

Planet MicroCap Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VMAR Vision Marine Technologies
$6.09 /

-0.095 (-1.54%)

GROW U.S. Global Investors
$7.26 /

-0.38 (-4.97%)

PYR PyroGenesis
$4.90 /

-0.02 (-0.41%)

SKYE Skye Bioscience
/

+

MEDS Trxade Group
$4.26 /

-0.05 (-1.16%)

ENVB Enveric Biosciences
$2.16 /

-0.12 (-5.26%)

SOLO ElectraMeccanica
$3.95 /

-0.115 (-2.83%)

CTHR Charles & Colvard
$2.79 /

-0.16 (-5.42%)

ARHH Assure Holdings
$1.24 /

-0.00099 (-0.08%)

HSDT Helius Medical
$17.09 /

-0.225 (-1.30%)

VMAR Vision Marine Technologies
$6.09 /

-0.095 (-1.54%)

01/11/21 ThinkEquity
Vision Marine Technologies initiated with a Buy at ThinkEquity
GROW U.S. Global Investors
$7.26 /

-0.38 (-4.97%)

PYR PyroGenesis
$4.90 /

-0.02 (-0.41%)

SKYE Skye Bioscience
/

+

MEDS Trxade Group
$4.26 /

-0.05 (-1.16%)

02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Maxim
Trxade Group initiated with a Buy at Maxim
12/03/20 National Securities
Trxade Group initiated with a Buy at National Securities
ENVB Enveric Biosciences
$2.16 /

-0.12 (-5.26%)

SOLO ElectraMeccanica
$3.95 /

-0.115 (-2.83%)

12/16/20 Stifel
ElectraMeccanica initiated with a Buy at Stifel
12/16/20 Colliers
ElectraMeccanica initiated with a Buy at Colliers
11/23/20 Roth Capital
ElectraMeccanica price target raised to $12.25 from $7.50 at Roth Capital
10/29/20 Roth Capital
Roth reiterates Buy rating on ElectraMeccanica after first deliveries from China
DUOT Duos Technologies Group
$7.99 /

-0.01 (-0.13%)

CTHR Charles & Colvard
$2.79 /

-0.16 (-5.42%)

BMM Bimini Mortgage Management
/

+

ARHH Assure Holdings
$1.24 /

-0.00099 (-0.08%)

HSDT Helius Medical
$17.09 /

-0.225 (-1.30%)

03/24/21
Fly Intel: Top five analyst initiations
03/24/21 Noble Capital
Helius Medical initiated with an Outperform at Noble Capital
02/12/21 Ladenburg
Helius Medical initiated with a Buy at Ladenburg
ISDR Issuer Direct
$24.52 /

+0.6 (+2.51%)

08/25/20 Northland
Issuer Direct price target raised to $18 from $16 at Northland
MEDS Trxade Group
$4.26 /

-0.05 (-1.16%)

SOLO ElectraMeccanica
$3.95 /

-0.115 (-2.83%)

CTHR Charles & Colvard
$2.79 /

-0.16 (-5.42%)

ARHH Assure Holdings
$1.24 /

-0.00099 (-0.08%)

  • 28
    Jan
  • 24
    Nov
SOLO ElectraMeccanica
$3.95 /

-0.115 (-2.83%)

HSDT Helius Medical
$17.09 /

-0.225 (-1.30%)

VMAR Vision Marine Technologies
$6.09 /

-0.095 (-1.54%)

SKYE Skye Bioscience
/

+

MEDS Trxade Group
$4.26 /

-0.05 (-1.16%)

ENVB Enveric Biosciences
$2.16 /

-0.12 (-5.26%)

HSDT Helius Medical
$17.09 /

-0.225 (-1.30%)

SOLO ElectraMeccanica
$3.95 /

-0.115 (-2.83%)

Conference/Events
Mistras management to meet virtually with Sidoti » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
MG

Mistras

$10.46 /

-0.54 (-4.91%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MG Mistras
$10.46 /

-0.54 (-4.91%)

MG Mistras
$10.46 /

-0.54 (-4.91%)

07/10/20 Sidoti
Mistras re-initiated with a Buy at Sidoti
05/12/20 Maxim
Mistras downgraded to Hold from Buy at Maxim
05/12/20 Maxim
Mistras downgraded to Hold from Buy at Maxim
MG Mistras
$10.46 /

-0.54 (-4.91%)

MG Mistras
$10.46 /

-0.54 (-4.91%)

Conference/Events
HP Enterprise participates in a conference call with Wells Fargo » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
HPE

HP Enterprise

$15.75 /

-0.215 (-1.35%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$15.75 /

-0.215 (-1.35%)

HPE HP Enterprise
$15.75 /

-0.215 (-1.35%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Jefferies
HP Enterprise initiated with a Buy at Jefferies
04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
HPE HP Enterprise
$15.75 /

-0.215 (-1.35%)

HPE HP Enterprise
$15.75 /

-0.215 (-1.35%)

HPE HP Enterprise
$15.75 /

-0.215 (-1.35%)

Conference/Events
Capital Markets Strategies to host a virtual summit » 04:55
04/21/21
04/21
04:55
04/21/21
04:55

Trading and Best…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Citrix upgraded to Buy from Hold at Jefferies » 04:53
04/21/21
04/21
04:53
04/21/21
04:53
CTXS

Citrix

$138.12 /

-0.61 (-0.44%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTXS Citrix
$138.12 /

-0.61 (-0.44%)

CTXS Citrix
$138.12 /

-0.61 (-0.44%)

04/13/21 BofA
Citrix reinstated with an Underperform at BofA
03/03/21 Citi
Citrix assumed with a Buy at Citi
01/20/21 RBC Capital
Citrix price target raised to $150 from $145 at RBC Capital
01/20/21 Citi
Citrix shares remain 'attractively priced,' says Citi
CTXS Citrix
$138.12 /

-0.61 (-0.44%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.